Immunovant, Inc. (IMVT) vs Iovance Biotherapeutics, Inc. (IOVA)
A side-by-side comparison of Immunovant, Inc. and Iovance Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMVT
Immunovant, Inc.
$32.58HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
IOVA
Iovance Biotherapeutics, Inc.
$13.17HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
Total return — IMVT vs IOVA
growth of $100 · dividends reinvested · last 7yIMVT +234.2% (+18.8%/yr)IOVA -35.5% (-6.1%/yr)IMVT compounded faster over this window
Log scale — wide-divergence pair
IMVT IOVA
IMVT vs IOVA: by the numbers
- •IMVT is the larger company ($6.72B vs $5.88B market cap).
- •Both run net losses; IOVA's is the smaller (-89.09% vs -7585.86% net margin).
Metrics side by side
Valuation
| Metric | IMVT | IOVA |
|---|---|---|
| P/S ratio | 947.79 | 18.10 |
| P/B ratio | 9.14 | 7.99 |
Profitability
| Metric | IMVT | IOVA |
|---|---|---|
| Gross margin | 0.00% | 97.23% |
| Operating margin | 0.00% | -153.08% |
| Net margin | -7585.86% | -89.09% |
| ROE | -73.19% | -39.33% |
| ROIC | -76.00% | -37.26% |
Growth (annualized)
| Metric | IMVT | IOVA |
|---|---|---|
| Total return CAGR (5Y) | 29.93% | -11.55% |
Frequently asked
- How have IMVT and IOVA total returns compared?
- Over the past 5 years, IMVT delivered 29.93% and IOVA delivered -11.55% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.